Obesity and the human microbiome

Current Opinion in Gastroenterology

Volumn 26, Issue 1, 2010, Pages 5-11

  Ley, Ruth E ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Gut microbial ecology; Inflammation; Insulin resistance; Metagenomics; Microbiota; Obesity

Indexed keywords

BACTERIAL METABOLISM; ENDOCRINE CELL; HUMAN; INSULIN RESISTANCE; INTESTINE FLORA; METAGENOMICS; MICROBIAL DIVERSITY; MICROBIOME; NONHUMAN; OBESITY; REVIEW; WEIGHT REDUCTION;

ANIMALS; BODY MASS INDEX; DIETARY FATS; ENERGY METABOLISM; GASTROENTERITIS; GASTROINTESTINAL TRACT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN RESISTANCE; METAGENOME; MICE; OBESITY; RATS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SWINE;

EID: 74249119678     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328333d751     Document Type: Review

References (54)

1. Power ML, Schulkin J. The evolution of obesity. Baltimore, MD: The Johns Hopkins University Press; 2009.
2. Ley RE, Bäckhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005; 102:11070-11075.
3. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444:1027-1031.
4. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444:1022-1023.
5. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature 2009; 457:480-484.
6. Schwiertz A, Taras D, Schafer K, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2009. doi: 10.1038/oby.2009.167. [Epub ahead of print]
7. Collado MC, Isolauri E, Laitinen K, Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 2008; 88:894-899.
8. Sotos M, Nadal I, Marti A, et al. Gut microbes and obesity in adolescents. Proc Nutrition Soc 2008, 67:E20.
9. Duncan SH, Lobley GE, Holtrop G, et al. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obesity 2008; 32:1720-1724.
10. Kalliomaki M, Collado C, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 2008; 87:534-538.
11. Santacruz A, Marcos A, Warnberg J, et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity 2009. doi: 10.1038/oby.2009.112. [Epub ahead of print]
12. Nadal I, Santacruz A, Marcos A, et al. Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. Int J Obesity 2009; 33:758-767.
13. Sabate J, Jouet P, Harnois F, et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obesity Surg 2008; 18:371-377.
14. Zhang H, DiBaise J, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 2009; 106:2365-2370.
15. Turnbaugh P, Gordon J. The core gut microbiome, energy balance, and obesity. J Physiol 2009; 587(Pt 17):4153-4258.
16. Guo X, Xia X, Tang R, et al. Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Lett Appl Microbiol 2008; 47:367-373.
17. Mozes S, Bujnakova D, Sefcikova Z, Kmet V. Developmental changes of gut microflora and enzyme activity in rat pups exposed to fat-rich diet. Obesity 2008; 16:2610-2615.
18. Mozes S, Bujnakova D, Sefcikova Z, Kmet V. Intestinal microflora and obesity in rats. Folia Microbiol (Praha) 2008; 53:225-228.
19. Turnbaugh P, Bäckhed F, Fulton L, Gordon J. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008; 3:213-223.
20. Waldram A, Holmes E, Wang Y, et al. Top-down systems biology modeling of host metabotype microbiome associations in obese rodents. J Proteome Res 2009; 8:2361-2375.
21. Duncan SH, Belenguer A, Holtrop G, et al. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 2007; 73:1073-1078.
22. Tap J, Mondot S, Levenez F, et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 2009; 11:2579-2584.
23. Crawford P, Crowley J, Sambandam N, et al. Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation. Proc Natl Acad Sci U S A 2009; 27:11276-11281.
24. Goodson JM, Groppo D, Halem S, Carpino E. Is obesity an oral bacterial disease? J Dent Res 2009; 88:519-523.
25. Reinhardt C, Reigstad CS, Bäckhed F. Intestinal microbiota during infancy and its implications for obesity. J Pediatr Gastroenterol Nutr 2009; 48:249-256.
26. Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Design 2009; 15:1546-1558.
27. Bäckhed F, Manchester J, Semenkovich C, Gordon J. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 2007; 104:979-984.
28. Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004; 101: 15718-15723.
29. Mandard S, Zandbergen F, van Straten E, et al. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 2006; 281:934-944.
30. Romeo S, Pennacchio L, Fu Y, et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet 2007; 39:513-516.
31. Staiger H, Haas C, Machann J, et al. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via PPAR {delta} and is of metabolic relevance in humans. Diabetes 2008; 53:579-589.
32. Hotamisligil GS, Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 2008; 8:923-934.
33. Hotamisligil G, Peraldi P, Budavari A, et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 1996; 271:665-670.
34. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56:1761-1772.
35. Tsukumo D, Carvalho-Filho M, Carvalheira J, et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007; 56:1886-1898.
36. Yang R-Z, Lee M-J, Hu H, et al. Acute-phase serum amyloid a: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med 2006; 3:e287.
37. Scheja L, Heese B, Zitzer H, et al. Acute-phase serum amyloid a as a marker of insulin resistance in mice. Exp Diabetes Res 2008; 2008:230837.
38. Reigstad CS, Lunden GO, Felin J, Bäckhed F. Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota. PLoS ONE 2009; 4:e5842.
39. Amar J, Burcelin R, Ruidavets JB, et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 2008; 87:1219-1223.
40. Ghoshal S, Witta J, Zhong J, et al. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 2009; 50:90-97.
41. Cani P, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57:1470-1481.
42. Ma X, Hua J, Li Z. Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol 2008; 49:821-830.
43. Cani P, Neyrinck A, Fava F, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007; 50:2374-2383.
44. Cani PD, Possemiers S, Van de Wiele T, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009; 58: 1091-1103.
45. Creely S, McTernan P, Kusminski C. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007; 292:E740.
46. Drucker D. Glucagon-like peptide 2. Trends Endocrinol Metab 1999; 10:153-156.
47. Uribe A, Alam M, Johansson O, et al. Microflora modulates endocrine cells in the gastrointestinal mucosa of the rat. Gastroenterology 1994; 107:1259-1269.
48. Bates J, Mittge E, Kuhlman J, et al. Distinct signals from the microbiota promote different aspects of zebrafish gut differentiation. Dev Biol 2006; 297:374-386.
49. Cani PD, Hoste S, Guiot Y, Delzenne NM. Dietary nondigestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr 2007; 98:32-37.
50. Samuel B, Shaito A, Motoike T, et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G proteincoupled receptor, Gpr41. Proc Natl Acad Sci U S A 2008; 105:16767-16772.
51. le Roux C, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007; 246:780-785.
52. Korner J, Inabnet W, Febres G, et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obesity 2009; 33:786-795.
53. Ishida R, Faintuch J, Paula A, et al. Microbial flora of the stomach after gastric bypass for morbid obesity. Obesity Surg 2007; 17:756-762.
54. Woodard G, Encarnacion B, Downey J, et al. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg 2009; 13:1198-1204.